BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 9888430)

  • 1. Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy.
    Ohguro H; Ogawa K; Nakagawa T
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):82-9. PubMed ID: 9888430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo.
    Ohguro H; Ogawa K; Maeda T; Maeda A; Maruyama I
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3160-7. PubMed ID: 10586938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of anti-recoverin autoantibodies in cancer-associated retinopathy.
    Adamus G; Guy J; Schmied JL; Arendt A; Hargrave PA
    Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2626-33. PubMed ID: 7688357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant expression of photoreceptor-specific calcium-binding protein (recoverin) in cancer cell lines.
    Maeda A; Ohguro H; Maeda T; Wada I; Sato N; Kuroki Y; Nakagawa T
    Cancer Res; 2000 Apr; 60(7):1914-20. PubMed ID: 10766180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recoverin, but not visinin, is an autoantigen in the human retina identified with a cancer-associated retinopathy.
    Polans AS; Burton MD; Haley TL; Crabb JW; Palczewski K
    Invest Ophthalmol Vis Sci; 1993 Jan; 34(1):81-90. PubMed ID: 8425844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of photoreceptor cell death in cancer-associated retinopathy.
    Maeda T; Maeda A; Maruyama I; Ogawa KI; Kuroki Y; Sahara H; Sato N; Ohguro H
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):705-12. PubMed ID: 11222531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and immunologic aspects of cancer-associated retinopathy.
    Ohguro H; Yokoi Y; Ohguro I; Mamiya K; Ishikawa F; Yamazaki H; Metoki T; Takano Y; Ito T; Nakazawa M
    Am J Ophthalmol; 2004 Jun; 137(6):1117-9. PubMed ID: 15183799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cancer-associated retinopathy antigen is a recoverin-like protein.
    Thirkill CE; Tait RC; Tyler NK; Roth AM; Keltner JL
    Invest Ophthalmol Vis Sci; 1992 Sep; 33(10):2768-72. PubMed ID: 1388144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo.
    Adamus G; Machnicki M; Elerding H; Sugden B; Blocker YS; Fox DA
    J Autoimmun; 1998 Oct; 11(5):523-33. PubMed ID: 9802939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Paraneoplastic retinopathy and anti-recoverin antibodies].
    Bataller L; Graus F; Dalmau J
    Neurologia; 2002 Mar; 17(3):156. PubMed ID: 11927105
    [No Abstract]   [Full Text] [Related]  

  • 11. Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation.
    Ohguro H; Ogawa K; Maeda T; Maruyama I; Maeda A; Takano Y; Nakazawa M
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2589-95. PubMed ID: 11581204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy.
    Polans AS; Witkowska D; Haley TL; Amundson D; Baizer L; Adamus G
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9176-80. PubMed ID: 7568096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Carcinoma-associated retinopathy: a review with clinical examples].
    Sobottka B; Schlote T; Besch D; Djelebova T; Wilhelm H; Zrenner E
    Klin Monbl Augenheilkd; 2000 Jan; 216(1):17-24. PubMed ID: 10702938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Paraneoplastic retinopathy in 2 patients with breast carcinoma].
    Huober J; Holz FG; Schmid H; Nölle B; Bellmann C; Krastel H; Wallwiener D; Bastert G
    Zentralbl Gynakol; 1997; 119(6):278-81. PubMed ID: 9312964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal ganglion cells recognized by serum autoantibody against gamma-enolase found in glaucoma patients.
    Maruyama I; Ohguro H; Ikeda Y
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1657-65. PubMed ID: 10845582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy.
    Thirkill CE; Keltner JL; Tyler NK; Roth AM
    Arch Ophthalmol; 1993 Jul; 111(7):931-7. PubMed ID: 8392327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors.
    Bazhin AV; Savchenko MS; Shifrina ON; Demoura SA; Chikina SY; Jaques G; Kogan EA; Chuchalin AG; Philippov PP
    Lung Cancer; 2004 May; 44(2):193-8. PubMed ID: 15084384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Carcinoma-associated retinopathy].
    Ohguro H; Maruyama I
    Ryoikibetsu Shokogun Shirizu; 2000; (31):73-6. PubMed ID: 11269192
    [No Abstract]   [Full Text] [Related]  

  • 19. Bilateral diffuse uveal melanocytic proliferation in a patient with cancer-associated retinopathy.
    Saito W; Kase S; Yoshida K; Ohguro H; Yokoi M; Iwaki H; Ohno S
    Am J Ophthalmol; 2005 Nov; 140(5):942-5. PubMed ID: 16310487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated retinopathy vs recoverin-associated retinopathy.
    Keltner JL; Thirkill CE
    Am J Ophthalmol; 1998 Aug; 126(2):296-302. PubMed ID: 9727525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.